Search for: "In re: Alcatel-Lucent USA Inc."
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
1 Jun 2010, 8:16 am
Alcatel-Lucent, sustained District Court judgement of validity and infringement by Microsoft of Alcatel-Lucent’s patent, Summer 2009 GlaxoSmithKline v. [read post]
25 Jan 2012, 8:57 am
It goes something like this: Plaintiff Eon sues defendants, including Alcatel-Lucent USA, Inc. [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
11 Apr 2008, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC overturns final judgment in Google’s favour in case brought by Leo Stoller who seeks to have Google’s trade mark declared generic: (IP Law360), (Trademark Blog), European Parliament says ‘no’ to disconnecting P2P users: (Ars Technica), (Techdirt), (Intellectual Property Watch), (Electronic… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
1 Feb 2008, 12:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
